radiotherapy

| 6 min read

Take a look into the making of the DDN Dialogues podcast episode: From warhead to cancer-killer, the quest for more actinium-225.

| 10+ min read

Actinium-225 is a radioactive isotope that kills cancer cells with a burst of alpha particles, but it was difficult to make enough of it — until now.

Understanding resistance to treatment

Page 1 of 1 - 3 Total Items

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Measuring mRNA and protein together at single cell resolution can uncover tumor-specific signaling activity and immune features.

Discover how CRISPR and single-cell RNA sequencing can connect disease-associated variants to regulatory elements, genes, and pathways.

Explore how human gut-liver models can improve the translation of preclinical findings into clinical pharmacokinetic predictions.